System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Mahsa Ghajarzadeh is an expert in Neurology at Washington University Medical Center (United States). As of October 2026, ScienceLeadR ranks Mahsa Ghajarzadeh in the top 1% of experts worldwide for Autoimmune Diseases. Mahsa Ghajarzadeh has authored 217 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 2 of them ongoing. SLR score: 666 (community average: 125). How the SLR is computed.

LeadR Profile

Mahsa Ghajarzadeh Washington University Medical Center United States
666 ScienceLeadR Reputation 666

Unlock

Register Login
Network Map

Neurology

Subspecialties: Internal Medicine - General Medicine - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2011 - 2026
Source: PubMed

Tehran University of Medical Sciences

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 217

Citations

Citations: 3 126 1st author: 45 Last author: 81 Unique author: 3

Main journals

Acta Med Iran 21
Maedica (Bucur) 21
Int J Prev Med 19
Neurol Sci 12
Mult Scler Relat Disord 11

Best Journals

Nat Med 3
Nature 2
BMJ 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Editorial: Monoclonal antibodies in treating multiple sclerosis (MS), and related diseases.
PMID 42876600 — sclerosis, multiple sclerosis, natalizumab, antibodies, neuromyelitis optica, antibodies, monoclonal		Front Neurol20260
Prevalence and Odds of Bipolar Disorder in Patients with Multiple Sclerosis (MS): a Systematic Review and Meta-Analysis.
PMID 42859432 — sclerosis, multiple sclerosis, bipolar disorder, odds ratio, prevalence		Maedica (Bucur)20260
Maternal diabetes as a prenatal risk factor for multiple sclerosis in offspring: a systematic review and meta-analysis.
PMID 42684490 — diabetes mellitus, sclerosis, multiple sclerosis, bias, publication bias, odds ratio, neurosciences, risk factors, records		Neurol Sci20260
The Prevalence and Risk of Polycystic Ovarian Syndrome (PCOS) in Women with Epilepsy: a Systematic Review and Meta-Analysis.
PMID 42416779 — epilepsy, ovary, prevalence, seizures, polycystic ovary syndrome		Maedica (Bucur)20260
Obesity and Risk of Pediatric-Onset Multiple Sclerosis (POMS): a Systematic Review and Meta-Analysis.
PMID 42416760 — sclerosis, multiple sclerosis, pediatric obesity, obesity, child		Maedica (Bucur)20260

Clinical Studies 2

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 2 2

By status:

Active not recruiting 1
Recruiting 1

By type:

Interventional 2

By Monocentric/Multicentric:

monocentric 2
multicentric2to4 0
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Solriamfetol for the Treatment of Multiple Sclerosis Fatigue
NCT06170970 — sclerosis, multiple sclerosis, fatigue, therapeutics, disorders of excessive somnolence, sleepiness		Phase 2Recruiting2024
Ketamine for Multiple Sclerosis Fatigue
NCT05378100 — sclerosis, multiple sclerosis, ketamine, midazolam, fatigue, therapeutics		Phase 2Active not recruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS